How HDM1005 affects common medications in healthy adults
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial studies how a new medicine, HDM1005, may change the way the body absorbs or processes some common medications like metformin, atorvastatin, warfarin, and digoxin. It may help doctors understand if HDM1005 can be taken safely with other drugs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 45 years old.
- Your weight is at least 50 kg for men or 45 kg for women, with a body mass index (BMI) between 24 and 35.
- You are generally healthy, with no major medical problems.
- You have not taken any prescription or over-the-counter medications, supplements, or herbal remedies in the last 2 weeks.
- You have not participated in another clinical trial or used an experimental product in the last 3 months.
- You are not pregnant or breastfeeding (if female).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental injection called HDM1005 for adults with obesity who do not have diabetes. The goal is to see if it helps with weight loss when combined with diet and exercise.
This study looks at how a new injection (HDM1005) is processed by the body in people with different levels of kidney function, including healthy volunteers. It aims to help understand dosing for people with kidney issues.
This study tests whether a new injectable medication called HDM1005 works as well as tirzepatide (a GLP-1 drug) for weight loss in adults with obesity but no diabetes. Both medications work similarly in the body to help control appetite and weight.
This trial tests a new medicine, HM17321, to see how the body processes it. It is for healthy adults and adults with obesity who want to help find new treatment options.
This early-stage study tests a new investigational medication in three groups: healthy adults with normal weight, adults who are overweight or obese, and men with type 1 diabetes who are also overweight. The research aims to understand how safe the medication is and how the body processes it.
This study tests how a new drug called HDM1002 interacts with common diabetes medications (metformin, empagliflozin) and other drugs like warfarin and valsartan. If you are a generally healthy adult (age 18-45) with a higher BMI, this trial helps ensure the new drug is safe when taken with other medicines.
Hear when a new Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.